Jad Adaimi

Jad Adaimi currently serves as Associate Program Team Lead (Rotation) and Executive Director, Therapeutic Area Head in Global Regulatory Affairs at Ultragenyx, focusing on regulatory strategy development for gene therapy in rare diseases, including neurodegenerative and bone diseases. Previously, Jad held key regulatory roles at Apollomics, CytomX Therapeutics, and Genentech, including Executive Director and Director positions. Jad's experience encompasses the management of global regulatory affairs and strategy for gene therapy. Jad also worked as a Regulatory Policy Regional Lead at Roche and as a researcher and instructor at Cal Poly State University. Educational credentials include a Bachelor of Science in Molecular and Cellular Biology and a Master's degree in Immune System Biology, both from California Polytechnic State University-San Luis Obispo.